Interventions for oral lichen planus: A systematic review and network meta-analysis of randomized clinical trials

K Sridharan1, G Sivaramakrishnan2

  • 1Department of Pharmacology & Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.

Abstract

Insights

Topical corticosteroids are the most effective treatment for oral lichen planus, showing superior clinical resolution and pain relief compared to other interventions. Other treatments like purslane and ozonized water also demonstrated benefits in clinical trials.

Area of Science:

  • Oral medicine
  • Dermatology
  • Pharmacology

Background:

  • Oral lichen planus (OLP) is a chronic inflammatory condition affecting oral mucosa.
  • Various treatments including corticosteroids, calcineurin inhibitors, and herbal drugs have been explored for OLP.
  • A comparative analysis of these interventions is crucial for evidence-based practice.

Purpose of the Study:

  • To conduct a network meta-analysis comparing different interventions for symptomatic oral lichen planus.
  • To evaluate the efficacy and safety of various treatment options based on existing clinical trials.

Main Methods:

  • Systematic search of electronic databases for randomized clinical trials on OLP interventions.
  • Inclusion of 55 trials involving 2831 patients.
  • Evaluation of outcomes including clinical resolution, clinical score, pain resolution, pain score, and adverse effects.

Main Results:

  • Corticosteroids, pimecrolimus, purslane, and ozonized water/corticosteroids showed significantly better clinical resolution than placebo.
  • Corticosteroids, ozonized water/corticosteroids, aloe vera, pimecrolimus, and hyaluronic acid were associated with superior pain resolution.
  • Pimecrolimus and cyclosporine use was linked to a higher risk of adverse effects.

Conclusions:

  • Topical corticosteroids emerge as the most effective drug class for treating oral lichen planus.
  • Several other interventions demonstrate potential benefits for OLP symptom management.
  • Further research may be needed to fully elucidate the risk-benefit profiles of all evaluated treatments.

Related Concept Videos

Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.8K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
286
Nursing Interventions I: Taxonomy of Nursing Interventions01:03

Nursing Interventions I: Taxonomy of Nursing Interventions

Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K